S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843300.49612.57 |
| _version_ | 1797281776622632960 |
|---|---|
| author | D. Noerenberg F. Briest C. Hennch K. Yoshida J. Nimo R. Hablesreiter Y. Takeuchi D. Sasca H. Ueno L. Mansouri Y. Inoue L. Wiegand A. M. Staiger B. Casadei M. Ziepert F. Asmar P. Korkolopoulou M. Kirchner P. Mertins J. Weiner E. Toth T. Weber A. Warth T. Schneider R.-M. Amini W. Klapper M. Hummel V. Poeschel G. Kanellis A. Rosenwald G. Held E. Campo K. Stamatopoulos I. Anagnostopoulos L. Bullinger N. Goldschmidt P. L. Zinzani C. Bödor R. Rosenquist T. P. Vassilakopoulos G. Ott S. Ogawa F. Damm |
| author_facet | D. Noerenberg F. Briest C. Hennch K. Yoshida J. Nimo R. Hablesreiter Y. Takeuchi D. Sasca H. Ueno L. Mansouri Y. Inoue L. Wiegand A. M. Staiger B. Casadei M. Ziepert F. Asmar P. Korkolopoulou M. Kirchner P. Mertins J. Weiner E. Toth T. Weber A. Warth T. Schneider R.-M. Amini W. Klapper M. Hummel V. Poeschel G. Kanellis A. Rosenwald G. Held E. Campo K. Stamatopoulos I. Anagnostopoulos L. Bullinger N. Goldschmidt P. L. Zinzani C. Bödor R. Rosenquist T. P. Vassilakopoulos G. Ott S. Ogawa F. Damm |
| author_sort | D. Noerenberg |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:02:19Z |
| format | Article |
| id | doaj.art-d54a8cd5040e4d8d8fba3b1b3fbe8223 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:02:19Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-d54a8cd5040e4d8d8fba3b1b3fbe82232024-03-03T03:19:23ZengWileyHemaSphere2572-92412022-06-0162310.1097/01.HS9.0000843300.49612.57202206003-00002S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOMED. Noerenberg0F. Briest1C. Hennch2K. Yoshida3J. Nimo4R. Hablesreiter5Y. Takeuchi6D. Sasca7H. Ueno8L. Mansouri9Y. Inoue10L. Wiegand11A. M. Staiger12B. Casadei13M. Ziepert14F. Asmar15P. Korkolopoulou16M. Kirchner17P. Mertins18J. Weiner19E. Toth20T. Weber21A. Warth22T. Schneider23R.-M. Amini24W. Klapper25M. Hummel26V. Poeschel27G. Kanellis28A. Rosenwald29G. Held30E. Campo31K. Stamatopoulos32I. Anagnostopoulos33L. Bullinger34N. Goldschmidt35P. L. Zinzani36C. Bödor37R. Rosenquist38T. P. Vassilakopoulos39G. Ott40S. Ogawa41F. Damm421 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan4 Department of Hematology, Oncology, and Pulmonary Medicine, University Medical Center, Johannes Gutenberg-University, Mainz, Germany2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan5 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany6 Department of Clinical Pathology, Robert-Bosch-Krankenhaus8 Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna10 Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany11 Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark12 First Department of Pathology, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece13 Core Unit Proteomics, Berlin Institute of Health, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine13 Core Unit Proteomics, Berlin Institute of Health, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine14 Core Unit Bioinformatics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany15 National Institute of Oncology, Budapest, Hungary16 Department of Internal Medicine IV, Haematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle17 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany18 National Institute of Oncology, Budapest, Hungary19 Department of Immunology, Genetics and Pathology, Uppsala University and University Hospital, Uppsala, Sweden20 Department of Pathology, Hematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig-Holstein, Kiel21 Department of Pathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin23 Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany24 Department of Hematopathology, Evangelismos General Hospital, Athens, Greece25 Institute of Pathology, University of Würzburg and Comprehensive Cancer Center (CCC) Mainfranken, Würzburg23 Department of Internal Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany27 Centro de Investigacion Biomedica en Red en Oncologia (CIBERONC), Madrid5 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden21 Department of Pathology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany31 Hadassah-Hebrew University Medical Center, Jerusalem, Israel9 Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy33 HCEMM-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary5 Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden35 Department of Hematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece6 Department of Clinical Pathology, Robert-Bosch-Krankenhaus2 Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan1 Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000843300.49612.57 |
| spellingShingle | D. Noerenberg F. Briest C. Hennch K. Yoshida J. Nimo R. Hablesreiter Y. Takeuchi D. Sasca H. Ueno L. Mansouri Y. Inoue L. Wiegand A. M. Staiger B. Casadei M. Ziepert F. Asmar P. Korkolopoulou M. Kirchner P. Mertins J. Weiner E. Toth T. Weber A. Warth T. Schneider R.-M. Amini W. Klapper M. Hummel V. Poeschel G. Kanellis A. Rosenwald G. Held E. Campo K. Stamatopoulos I. Anagnostopoulos L. Bullinger N. Goldschmidt P. L. Zinzani C. Bödor R. Rosenquist T. P. Vassilakopoulos G. Ott S. Ogawa F. Damm S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME HemaSphere |
| title | S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME |
| title_full | S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME |
| title_fullStr | S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME |
| title_full_unstemmed | S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME |
| title_short | S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME |
| title_sort | s101 genetic and epigenetic factors driving primary mediastinal b cell lymphoma pathogenesis and outcome |
| url | http://journals.lww.com/10.1097/01.HS9.0000843300.49612.57 |
| work_keys_str_mv | AT dnoerenberg s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT fbriest s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT chennch s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT kyoshida s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT jnimo s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT rhablesreiter s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT ytakeuchi s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT dsasca s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT hueno s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT lmansouri s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT yinoue s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT lwiegand s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT amstaiger s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT bcasadei s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT mziepert s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT fasmar s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT pkorkolopoulou s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT mkirchner s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT pmertins s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT jweiner s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT etoth s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT tweber s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT awarth s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT tschneider s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT rmamini s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT wklapper s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT mhummel s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT vpoeschel s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT gkanellis s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT arosenwald s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT gheld s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT ecampo s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT kstamatopoulos s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT ianagnostopoulos s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT lbullinger s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT ngoldschmidt s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT plzinzani s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT cbodor s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT rrosenquist s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT tpvassilakopoulos s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT gott s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT sogawa s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome AT fdamm s101geneticandepigeneticfactorsdrivingprimarymediastinalbcelllymphomapathogenesisandoutcome |